Myprotein’s parent company says it cashes in on demand for protein supplements, reporting sales growth that is driven in part by higher prices reflecting increased input costs for products such as whey. The company also signals caution, warning that new EU tariffs could affect future costs and pricing.
The outlets describe how the firm benefits from a broader “protein boom” in consumer demand, but notes that margins and growth are sensitive to changes in trade policy. One source highlights that price rises play a role in performance, tied to the higher cost of whey. Another source focuses on the same overall picture of growth while stressing the potential impact of tariff changes as the key risk.
Together, the reporting indicates that near-term results are supported by strong market demand and pricing decisions linked to ingredient costs, while the outlook depends on how EU tariffs influence supply chain expenses and competitive positioning.
